Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial.

Funt SA, Lattanzi M, Whiting K, Al-Ahmadie H, Quinlan C, Teo MY, Lee CH, Aggen D, Zimmerman D, McHugh D, Apollo A, Durdin TD, Truong H, Kamradt J, Khalil M, Lash B, Ostrovnaya I, McCoy AS, Hettich G, Regazzi A, Jihad M, Ratna N, Boswell A, Francese K, Yang Y, Folefac E, Herr HW, Donat SM, Pietzak E, Cha EK, Donahue TF, Goh AC, Huang WC, Bajorin DF, Iyer G, Bochner BH, Balar AV, Mortazavi A, Rosenberg JE

Open source

DOI: 10.1200/jco.21.01485
Published: 2022 Apr 20
Container: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/jco.21.01485,
  title = {Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial.},
  author = {Funt SA and Lattanzi M and Whiting K and Al-Ahmadie H and Quinlan C and Teo MY and Lee CH and Aggen D and Zimmerman D and McHugh D and Apollo A and Durdin TD and Truong H and Kamradt J and Khalil M and Lash B and Ostrovnaya I and McCoy AS and Hettich G and Regazzi A and Jihad M and Ratna N and Boswell A and Francese K and Yang Y and Folefac E and Herr HW and Donat SM and Pietzak E and Cha EK and Donahue TF and Goh AC and Huang WC and Bajorin DF and Iyer G and Bochner BH and Balar AV and Mortazavi A and Rosenberg JE},
  year = {2022},
  journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  doi = {10.1200/jco.21.01485},
  url = {https://doi.org/10.1200/jco.21.01485}
}

RIS

TY  - JOUR
TI  - Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial.
AU  - Funt SA
AU  - Lattanzi M
AU  - Whiting K
AU  - Al-Ahmadie H
AU  - Quinlan C
AU  - Teo MY
AU  - Lee CH
AU  - Aggen D
AU  - Zimmerman D
AU  - McHugh D
AU  - Apollo A
AU  - Durdin TD
AU  - Truong H
AU  - Kamradt J
AU  - Khalil M
AU  - Lash B
AU  - Ostrovnaya I
AU  - McCoy AS
AU  - Hettich G
AU  - Regazzi A
AU  - Jihad M
AU  - Ratna N
AU  - Boswell A
AU  - Francese K
AU  - Yang Y
AU  - Folefac E
AU  - Herr HW
AU  - Donat SM
AU  - Pietzak E
AU  - Cha EK
AU  - Donahue TF
AU  - Goh AC
AU  - Huang WC
AU  - Bajorin DF
AU  - Iyer G
AU  - Bochner BH
AU  - Balar AV
AU  - Mortazavi A
AU  - Rosenberg JE
PY  - 2022
JO  - Journal of clinical oncology : official journal of the American Society of Clinical Oncology
DO  - 10.1200/jco.21.01485
UR  - https://doi.org/10.1200/jco.21.01485
ER  -

APA

SA, F., M, L., K, W., H, A., C, Q., MY, T., CH, L., D, A., D, Z., D, M., A, A., TD, D., H, T., J, K., M, K., B, L., I, O., AS, M., G, H., A, R., M, J., N, R., A, B., K, F., Y, Y., E, F., HW, H., SM, D., E, P., EK, C., TF, D., AC, G., WC, H., DF, B., G, I., BH, B., AV, B., A, M., & JE, R. (2022). Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. https://doi.org/10.1200/jco.21.01485

Source records

pubmed · retrieved 2026-09-26T23:27:55.350Z